Prostate-specific antigen response and clinical progression-free survival in Black and White men with chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide in a real-world setting

Prostate Cancer and Prostatic Diseases, Published online: 14 December 2022; doi:10.1038/s41391-022-00622-6Prostate-specific antigen response and clinical progression-free survival in Black and White men with chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide in a real-world setting

Source: Prostate Cancer and Prostatic Diseases - December 14, 2022 Category: Urology & Nephrology Authors: Stephen J. Freedland Agnes Hong Nader El-Chaar Sharanya Murty Krishnan Ramaswamy Anna D. Coutinho David Nimke Alicia K. Morgans Source Type: research